Publications by authors named "Haige Ye"

Claim this Profile
P
Pegylated Liposomal Doxorubicin Confers a High Risk for Pneumocystis Jirovecii Pneumonia in Patients With Diffuse Large B-Cell Lymphoma.
Siqian Wang, Xi Xu, Yongyong Ma, Shanhu Qian, Liyuan Tang, Haige Ye

Clin Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Retracted] IQGAP1 plays an important role in the cell proliferation of multiple myeloma via the MAP kinase (ERK) pathway.
Yongyong Ma, Zhouxiang Jin, Jin Huang, Shujuan Zhou, Haige Ye

Oncol Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
POD24-Based prognostic signature enables personalized risk stratification in mantle cell lymphoma.
Yizi He, Caiqin Wang, Tao Pan, Qingqing Cai, Dehui Zhou, Haige Ye

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting.
Yilan Xu, Danyang Li, Na Wang, Bei Ge, Chen Meng, Haige Ye

Clin Epigenetics· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of ZR2 versus R-CHOP-like for elderly patients with newly diagnosed diffuse large B cell lymphoma: a single-center prospective study in China.
Panruo Jiang, Rongqi Li, Hui Li, Yilan Xu, Zhenyan Xu, Haige Ye

Ann Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China.
Rongqi Li, Yuhan Zeng, Yizhang Chen, Zhongjiang Ye, Chuang Chen, Haige Ye, Ziye Zhou

Front Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Jiangfang Feng, Yue Fei, Meng Gao, Xiangrui Meng, Dongfeng Zeng, Haige Ye

Hematol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges for anti-CD47 antibodies in hematological malignancies.
Yilan Xu, Panruo Jiang, Zhenyan Xu, Haige Ye

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
Danyang Li, Yigang Yuan, Chen Meng, Zihan Lin, Min Zhao, Daijiao Ye, Haige Ye

Clin Epigenetics· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE.
Dongfeng Zeng, Yu Fang, Yue Fei, Rong Liang, Haige Ye

Int J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
Sisi Ye, Fang Xiong, Xiaofei He, Yigang Yuan, Danyang Li, Daijiao Ye, Haige Ye

Theranostics· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
pneumonia in non-Hodgkin's lymphoma after rituximab-based chemotherapy: a case series.
Qianying Zhang, Liang Han, Yuanyuan Lin, Xiaohong Sun, Haige Ye

Transl Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane.
Bin Liang, Dawei Jiang, Luqi Pan, Fang Xiong, Shuya Feng, Haige Ye

Acta Biomater· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of PI3K and BCL-2 overcomes ibrutinib resistance in aggressive mantle cell lymphoma.
Haige Ye, Shengjian Huang, Yang Liu, Zhihong Chen, Michael Wang

J Cell Mol Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in understanding the mechanisms of resistance to BCL-2 inhibitors.
Yilan Xu, Haige Ye

Exp Hematol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in molecular feature of smoldering mantle cell lymphoma.
Panruo Jiang, Aakash Desai, Haige Ye

Exp Hematol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron overload adversely effects bone marrow haematogenesis via SIRT-SOD2-mROS in a process ameliorated by curcumin.
Shujuan Zhou, Lan Sun, Shanhu Qian, Yongyong Ma, Ruye Ma, Haige Ye

Cell Mol Biol Lett· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.
Bin Zhou, Xianghong Jin, Weiwei Jin, Xingzhou Huang, Yanfei Wu, Haige Ye

J Transl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of hypoalbuminemia at diagnosis in non-M3 acute myeloid leukemia.
Na Wang, Aakash Desai, Bei Ge, Wenya Li, Xianghong Jin, Haige Ye

Leuk Lymphoma· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mechanism of SP1/p300 complex promotes proliferation of multiple myeloma cells through regulating IQGAP1 transcription.
Zhouxiang Jin, Shujuan Zhou, Haige Ye, Songfu Jiang, Kang Yu

Biomed Pharmacother· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting miR-193a-AML1-ETO-β-catenin axis by melatonin suppresses the self-renewal of leukaemia stem cells in leukaemia with t (8;21) translocation.
Bin Zhou, Haige Ye, Chongyun Xing, Bin Liang, Haiying Li

J Cell Mol Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline Treatment for Older Patients with Mantle Cell Lymphoma.
Haige Ye, Aakash Desai, Dongfeng Zeng, Jorge Romaguera, Michael L Wang

Oncologist· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.
Haige Ye, Aakash Desai, Shengjian Huang, Dayoung Jung, Richard Champlin

J Exp Clin Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous regression of mantle cell lymphoma: a report of four cases.
Haige Ye, Aakash Desai, Tiejun Gong, Dongfeng Zeng, Krystle Nomie

Cancer Commun (Lond)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of the red blood cell distribution width that maintain at high level following completion of first line therapy in mutiple myeloma patients.
Yongyong Ma, Zhouxiang Jin, Shujuan Zhou, Haige Ye, Songfu Jiang

Oncotarget· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis